UPS has announced the launch of UPS Temperature True Cryo in Europe. The service is expected to provide healthcare customers access to end-to-end product protection and the capability to ship parcels in a cryogenic environment. The service is set to include real-time tracking and intervention, which, when combined with UPS’s risk mitigation solutions and global network of control towers, is due to provide visibility for shipments at each stage of the supply chain journey.
The solution is to use Cryoport’s cryogenic containers which are expected to allow UPS customers to use liquid nitrogen stored in dry vapour form to keep products frozen at -150°C for 10 days while in transit or storage. When meeting minimum volume levels, shipments are also expected to be able to pair with UPS Proactive Response Secure, a financial protection service that provides coverage for these time- and temperature-sensitive shipments.
Jan Denecker, Director of Healthcare Marketing & Strategy, UPS Europe, said, “When products requiring cryopreservation are on the move, customers want peace of mind that their shipments are safeguarded, so bringing this solution to the Europe market was a logical next step as we continue to expand our best-in-class logistics services globally for the healthcare and life science industries,” adding, “UPS Temperature True Cryo combines innovative packaging, 24/7 monitoring and intervention capabilities for the most critical time- and temperature-sensitive specimens across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health.”
The world's largest collection of global supply chain intelligence